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At least twenty-one kindred representing fifty-nine histologically proven cases 
of pheochromocytoma have been reported in the literature (ref: 1 - 24). Eleven of 
these fifty-nine individuals had an associated carcinoma of the thyroid gland and a 
lesser number had parathyroid tumors. (See Table I ) 
Five percent of the reported pheochromocytomas have had a familial association.' 
Such estimations have been admittedly gross due to the fact that the familial nature 
of this tumor first came to light only twenty years ago. Judging from published 
data, numerous authors appear to lack cognizance of the familial concentration shown 
by this tumor. 
The actual proportion of hereditary pheochromocytomas is unknown. Probably 
it is higher than published reports indicate since such factors as the time needed 
for a familial tumor to become manifest in successive generations, the generally 
poor knowledge most patients have of their family medical history and the difficulty — 
if not the impossibility — of ascertaining with certainty the cause of death of 
long-deceased individuals, militate against recognition of familial prevalence. 
Twenty-nine cases of pheochromocytoma have been seen at the Henry Ford 
Hospital since 1951. This study consists of a retrospective survey of eleven families 
of these patients. The co-operating patients and their relatives sought out other 
relatives, family physicians, family bibles and other familial depositories of information 
in an attempt to determine the state of health of living relatives and the cause of 
death of deceased family members. Physical examinations were done on those 
relatives who had a suggestive medical history and who could or would come to 
the hospital for examination. Pharmacological screening tests (histamine, regitine 
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Table I 
case 
number family sex/age relationship site reference 
i . A f - 18 bilateral (2) Fraenkel 
2. A m - 50 nephew (case 1) bilateral (3) Lohmann 
3. A f - 39 niece (case 1) bilateral (4) Volhard 
4. A m - 44 nephew (case 1) bilateral (3) Lohmann 
5. H f - 26 bilateral (5) Calhins and 
Howard 
6. H f - 17 niece (case 5) bilateral (6) Hyman and 
Mencher 
7. C f - 18 bilateral* (7) (8) Manning et al. 
Roth et al. 
s. c f - 28 sister (case 7) bilateral (7) (8) Roth et al. 
9. c m - 25 brother (case 7) bilateral (7) (8) Roth et al. 
10. D 111 - 15 left (9) Young and Murray 
11. D f - 12 sister (case 10) left (9) Young and Murray 
12. E f - 18 bilateral (10) Kelsall and Ross 
13. E f - 14 sister (case 12) bilateral (10) Kelsall and Ross 
14. F m - 6 
15. F f - 26 
16. V m - 16 
right 
aunt (case 14) 
son (case 15) 
cousin (case 14) 
(11) Cone et al. 
(11) Cone et al. 
(11) Cone et al. 
17. f bilateral (11) Cone et al. 
18. G f - 8 daughter (case 17) bilateral (11) Cone et al. 
intrathoracic 
19. G f - 6 daughter (case 17) right & (11) Cone et al. 
bifurcation 
of aorta 
20. H m - 26 left (12) Greenberg and 
Gardner 
21. I I m - 3 son (case 20) left (12) Greenberg and 
Gardner 
22. 1 m - 31 aortic 
bifurcation 
(13) Cook et al. 
23. 1 f - 4 2 sister (case 22) aortic 
bifurcation 
(13) Cook et al. 
24. .1 m - 57 bilateral (14) Carmen and 
Brashear 
25. J m - 22 son (case 22) right (14) Carmen and 
Brashear 
26. J f - 17 daughter (case 22) left (14) Carmen and 
Brashear 
27. K f - 58 left (15) Hradec 
28. K m - 36 son (case 27) left (15) Hradec 
29. K m - 32 son (case 27) right (15) Hradec 
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case 
number family sex/age 
30. L m - 62 
31. L m - 31 
32. L m - 30 
33. 1. f - 15 
58. 
59. 
Table I (continued) 
relationship 
11 
IJ 
nephew (case 30) 
nephew (case 30) 
niece (case 30) 
site 
bilateral* 
bilateral 
left 
right 
reference 
(16) Smits and 
Huizenga 
(16) Smits and 
Huizenga 
(16) Smits and 
Huizenga 
(16) Smits and 
Huizenga 
34. M m - 57 bilateral (17) Hill and Smith 
35. M f - 17 daughter (case 34) left (17) Hill and Smith 
36. M 111 - 20 son (case 34) right (17) Hill and Smith 
37. N f - 32 bilateral* (18) Nourok 
38. N f - 33 daughter (case 37) bilateral* (18) Nourok 
39. O m bilateral (19) Finegold and 
Hadded 
40. o 111 son (case 39) bilateral* (19) Finegold and Hadded 
41. P m - 55 right* (20) Cushman 
42. I ' m - 32 son (case 41) left* (20) Cushman 
43. Q m - 34 left (20) Cushman 
44. Q m - 13 son (case 43) right (2) (20) Cushman 
45. 0 m - 17 son (case 43) bilateral (20) Cushman 
46. 0 m - 11 grandnephew bilateral (20) Cushman 
(case 43) 
47. R m - 15 bilateral (21) VonHagon and 
Barrows 
48. R f - 13 sister (case 47) right (21) VonHagon and 
Barrows 
49. S 111 - 21 right -1- extra a (22) Tisherman 
50. S i l l - 21 1st cousin (case 49) right (22) Tisherman 
51. S f - 6 niece (case 50) pre-aortic (22) Tisherman 
52. s ni - 16 grandnephew (case 54) 
son (case 55) 
left (22) Tisherman 
5.?. s 111 - 37 nephew (case 54) left adrenal (22) Tisherman 
54. 
,s 11) - 54 uncle (case 53) 2nd cousin (case 49, 
50) 
left adrenal (22) Tisherman 
55. T f - 27 bilateral* (23) Schimke and 
Hartmann 
56. T f - 18 niece (case 55) bilateral* (23) Schimke and 
Hartmann 
57. 1 111 . 39 cousin (case 55) bilateral* (23) Schimke and 
Hartmann 
f - 2 8 bilateral* 
brother (case 58) 
(23) Schimke and 
Hartmann 
Frunstein and 
Finkelstein 
*also had cancer of the thyroid gland. 
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tests) and/or catecholamine analysis of urine specimens were done on those relatives 
in whom physical examination demonstrated signs of symptoms suspicious of pheo-
chromocytoma. Using these methods, the health status of 253 relatives, living and 
dead, of pheochromocytoma patients was determined. 
Findings: 
Seven of twenty-two parents of pheochromocytoma patients had had hypertension, 
two had had diabetes. Of forty siblings surveyed, four were found to have hypertension 
and two to have diabetes. Nineteen children of pheochromocytoma patients were 
surveyed and two cases of hypertension were found. Altogether, thirteen instances 
of hypertension and four cases of diabetes mellitus were found in eighty-one close 
relatives of pheochromocytoma patients. No other significant pathology was discovered. 
Twenty-eight of these individuals were examined clinically by the authors. 
Family studies: (See Diagram p. 471) 
Family I: 
A girl, eighteen years old, from whom a pheochromocytoma had been successfully 
removed, reported a brother aged 23 who had been diabetic since age 17. Examination 
of the brother and other family members failed to disclose evidence of pheochromo-
cytoma. 
Family II: 
A middle aged woman who died of complications of pheochromocytoma had 
a father who had died at age 59 following a cholecystectomy, because of uncontrollable 
diabetes. The family physician, when interviewed, possessed no evidence suggestive 
of pheochromocytoma in his case record. Autopsy had not been performed. Her 
mother had been hypertensive and died accidentally at age seventy-five. Her paternal 
grandfather, diabetic, had died of "sun-stroke", age fif ty. The patient's sister was 
examined and tested for pheochromocytoma with negative results, as was a niece. 
Family IH: 
A middle aged man died of complications of undiagnosed pheochromocytoma. 
Three siblings were reported to be hypertensive by his wife, one of whom was tested 
and found to be negative for evidence of pheochromocytoma. His father had died 
at age sixty-five of a cerebral hemorrhage and "blood pressure so high it couldn't be 
read" and his mother had died at fifty-two of uremia, cardiomegaly, diabetes and 
hypertension. A maternal uncle had died at age eighty of diabetes and hypertension. 
None of these suspect relatives had been autopsied. 
Family IV: 
This middle aged negro woman, despite the removal of a pheochromocytoma 
still displays mild hypertension (150/100), but has no evidence of recurrence of 
tumor. Her father is hypertensive. He declined examination. She reported that ten 
siblings and fifty-five nieces and nephews are living and well. 
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FINDINGS IN n PHEOCHROMOCYTOMA FAMILIES 
( p a r t i a l r e p r e s e n t a t i o n ) 
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Family V: 
This sixty-three year old man who died of complications of pheochromocytoma 
had four chOdren. There was no history of suspicious illness in his parents. Three 
of his four children, includuig one hypertensive, were examined and tested. No 
evidence of pheochromocytoma was found. The possibility of this tumor has not 
been excluded in the remaining son, who is hypertensive. 
Family VI: 
This middle aged woman has mild (140/100) hypertension three years after 
removal of a pheochromocytoma without evidence of recurrence. She denied related 
illness in her parents or her child. Her mother had died, aged forty-eight, of peritonitis. 
No autopsy. 
Family VII: 
This middle aged man, childless, had had a pheochromocytoma removed four 
years previously and now has mUd hypertension (150/95) with nega,tive tests for 
recurrence. His father died of cerebral hemorrhage and hypertension at age sixty-nine 
and his paternal aunt died of diabetes at age sixty-five. Diabetes was also diagnosed 
in a maternal uncle who had died of cancer of the liver at age sixty-eight. None of 
these three relatives were autopsied. 
Family VIII: 
This forty-two year old woman is living and well two years following the removal 
of a pheochromocytoma. Her diabetic maternal aunt was not able to come for 
examination, but reportedly has no hypertension. A fif ty year old diabetic sister was 
examined with negative tests for pheochromocytoma as also was her forty year old 
sister, a woman with emotional instability similar to that which the patient had 
exhibited prior to removal of her tumor. 
Family IX: 
This thirty-three year old man is well and normotensive nine years following 
removal of a pheochromocytoma. His father, a hypertensive, refused to come for 
examination. His paternal grandfather had died of a CVA at an elderly age. A 
maternal uncle is reportedly hypertensive but the patient's mother is living and well. 
Family X: 
This middle aged woman presented clinically with Cushing's syndrome but was 
found at post-mortem examination to have bilateral pheochromocytomata, multiple 
parathyroid adenomas and metastatic carcinoma of the thyroid gland (medullary type, 
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previously resected) to the liver and lungs. Her father had died at age thirty-three 
of "sun-stroke". A brother had died at thirty-one of a perforated ulcer and a sister 
had died at thirty-three following a gynecological operation. None had been autopsied. 
Both daughters of this patient were examined and found to be free of symptoms of 
either pheochromocytoma or thyroid malignancy. 
Family XI: 
This middle aged man had had bilateral pheochromocytomas removed. Presently, 
he has evidence of recurrent tumor. His hypertensive sister had negative pharma-
cological tests and catecholamine studies. The patient's mother had died at age 
fifty-eight of high blood pressure. She had suffered from severe headaches for 
approximately eight years prior to her death. Unfortunately, no autopsy had been 
performed. 
COMMENT 
Pheochromocytoma may be either familial or sporadic. Some of the sporadic 
cases may represent new mutations and eventually give rise to familial pheochromo-
cytomata. 
The object of the present study was to determine, in a small series, what 
percentage of pheochromocytoma cases might be of familial origin. While no definite 
pheochromocytomas were found among the more than two hundred relatives surveyed, 
the frequency of familial incidence remains in doubt. The possibility of pheochromo-
cytoma cannot be excluded in sixteen relatives from nine families, who had had 
symptoms compatible with those produced by these neoplasms. 
Family X, one member of which had developed neoplasms of the adrenal, thyroid 
and parathyroid glands is of particular interest. The sudden deaths of the patient's 
father and two siblings (ascribed to other causes) is suggestive of pheochromocytoma 
which is notorious in this respect. Two daughters of this patient, living and well, 
have been instructed concerning the need for periodic examinations. 
Many of the problems inherent in determining the true familial incidence of 
any disease were encountered in this study. 
1) Most patients had an appallingly poor knowledge of their family medical 
history. Such vague causes of death as "old age", sun-stroke, natural causes, child-
birth and operations were frequent. Autopsy or medical records concerning such 
cases were non-existant or unavailable in most cases. Many ancestors and near 
relatives of our patients "died in the old country." Unfortunately, most of these old 
countries have since become new countries, discarding not only old ideals, traditions 
and socio-economic systems but medical records as well. 
2) Familial diseases, excepting those which become apparent in ea,rly childhood, 
require many years for manifestation of their familial character. Lohmann,^ in 1950, 
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investigating the occurrence of pheochromocytomata in three siblings, discovered that 
these patients were related to the original pheochromocytoma patient described by 
Fraenkel in 1886.^  Similarly, twenty-two years elapsed between the detection of 
pheochromocytomata in a mother and her daughter reported by Nourok." Clearly, 
the fact that the disease has not appeared in relatives of our probands to date does 
not mean that it may not do so in the future. 
A factor which leads to overestimation of the familial incidence of this tumor 
is the tendency to accept suggestive clinical evidence without pathological con-
firmation as indicative of the disease in families of probands. In at least four 
instances, clinical evidence led us to a high degree of suspicion concerning the 
presence of a pheochromocytoma in a sibling of a patient. In all four cases, 
however, our suspicions were proven false by appropriate pharmacological and chemical 
tests. 
Diabetes was present in six families and hypertension in seven. The significance 
of these findings is uncertain. However, these families do appear to have an 
abnormally high incidence of these two diseases. 
Smits and Huizenga" studied a large family of over sixty members in which 
they found pheochromocytoma in four persons and probable pheochromocytomata 
in ten others. They concluded that the mode of inheritance of pheochromocytoma 
could be explained by the presence of one dominant gene as the etiological factor. 
How many of Smits and Huizenga's ten "probable" cases would have been found 
positive for the diagnosis on direct test is doubtful, in view of our experience with 
similar patients. Until it is possible to gather more direct evidence, it is best to 
reserve judgement regarding the specific mode of inheritance. 
Tisherman et al" surveyed 199 members of a family and found seven proved 
and one probable pheochromocytomata in seven members, hypertension of un-
established origin in thirty others, cafe'-au-lait spots over 1.5 cm. in diameter (possible 
formes frustes of neurofibromatosis) in twenty-two, extensive hemangiomas in two 
and Hippel's disease in two. In addition, they suggested an association between 
pheochromocytoma and congenital cataract. 
A recent review by Sapira et al^' of pheochromocytoma occurring in association 
with thyroid carcinoma (Sipple's syndrome)" calls attention both to the high incidence 
of familial pheochromocytomata (six of eighteen patients had a family history of 
pheochromocytoma) and the high incidence of bilateral adrenal tumors (thirteen out 
of eighteen) in these cases. 
More recently, Schimke and Hartmann" reported two additional cases of pheo-
chromocytoma and thyroid carcinoma and provided further data on a case previously 
reported by Beer. In addition, they" discovered that previous familial case reported 
by Grunstein and Finkelstein,^* originally thought to have bilateral pheochromocyto-
mata metastatic to the thyroid, had, in fact, bilateral pheochromocytomata and a 
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typical amyloid producing medullary carcinoma of the thyroid. This uncommon 
type of thyroid carcinoma has been found in a clear majority of thyroid malignancies 
associated with pheochromocytoma. 
An additional case of bilateral pheochromocytoma, medullary carcinoma of the 
thyroid and multiple parathyroid adenomata (see Family X ) has been encountered 
in our experience and will be reported in detail elsewhere. '^ 
Adding the above cases to previous experience, we find that eighteen of the 
twenty-two reported cases of pheochromocytoma associated with thyroid carcinoma 
were bilateral. I t should be noted that two of the four patients with unilateral 
tumors were alive at the time of publication and could conceivably develop contra-
lateral adrenal tumors in the future. Sixteen of the twenty-three reported cases of 
Sipple's syndrome were females but further reports are needed before the significance 
of this sex distribution can be evaluated. 
Schimke and Hartmann" maintain that the thyroid carcinoma occurring with 
familial pheochromocytoma is invariably of the medullary type and that there is 
strong evidence supporting the contention that these two tumors are products of the 
same genetic defect. 
Some authors"'" have suggested that the association of pheochromocytoma with 
thyroid carcinoma and, less often, with parathyroid adenoma might represent a 
variant of the multiple endocrine adenomatosis (MEA) syndrome. Schimke and 
Hartman point out that the absence of involvement of other endocrine organs 
(pancreas etc.) in the thyroid malignancy- pheochromocytoma syndrome, the low 
incidence of thyroid malignancy in the MEA syndrome, and the lack of increased 
peptic ulcer incidence in association with pheochromocytoma, suggests that the pheo-
chromocytoma- medullary thyroid carcinoma syndrome is a genetically distinct entity." 
The slight male preponderance (34 to 25) in familial pheochromocytoma is 
probably of littie significance. The high incidence of bilateral tumors (23 out of 59) 
is consistant with the observation that inherited tumors tend to multiplicity. It is 
noteworthy that familial pheochromocytomata seem to occur at an earlier age than 
the sporadic form, only 9 of 59 familial cases being past the age of forty. 
More important, perhaps, is the tendency for familial pheochromocytomata to 
appear at an earlier age in each succeeding generation, (see Table I I ) . This tendency 
to an earlier phenotypic manifestation of genotypic status has been noted in other 
familial malignant tumors, such as carcinoma of the breast. The factors underlying 
this phenomenon, when understood, will undoubtedly contribute greatly to the 
knowledge and understanding of individual resistance to neoplastic disease and the 
nature of the neoplastic process. 
It is clear that in some families, pheochromocytoma is highly concentrated and 
follows a pattern of incidence consistant with dominant gene inheritance." 
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However, in some families, parents of uniformly affected siblings have not mani-
fested the disease. 
If all cases of pheochromocytoma were inherited on a dominant non-sex linked 
basis, our direct examination of twenty-five siblings of probands in the tumor age 
group should certainly have revealed some additional cases. The fact that none 
of our probands have demonstrably diseased siblings indicates that, while familial 
determination may underlie some cases, it certainly is not responsible for all. 
Our experience favors the hypothesis that sporadic cases are more frequent than 
familial cases or else that, if the disease has a genetic etiology, the penetrance of 
the gene and its phenotypic expression are subject to suppression by other biological 
factors. In this connection it can be noted that only four neoplasms of man are 
known to be inherited as dominant conditions and all of these manifest themselves 
in early childhood or adolescence. Pheochromocytoma occurrs in childhood in only 
ten percent of cases. 
The occasional appearance of pheochromocytoma in association with familial 
neurofibromatosis, von-Hippel-lindaus' disease and familial medullary carcinoma of 
the t h y r o i d , ' a l s o casts doubt on the hypothesis that the inheritance is of the 
simple dominant pattern. 
Genetically linked neoplasias in general have been found to be the result of 
multiple etiologic determinants, and the common variety of pheochromocytoma would 
appear to be no exception to this rule. 
Based upon the knowledge obtained in these studies, the following conclusions 
may be drawn: 
1) Famihal pheochromocytoma is a condhion of high penetrance but many 
cases appear to be sporadic or non-familial in character. 
2) Nevertheless, all pheochromocytoma patients (particularly those with bilateral 
tumors) and their families should have careful periodic examinations with special 
attention to the adrenal, thyroid and parathyroid glands because of the demonstrated 
familial concentration of the disease in some families. The possible concurrence of 
neuroectodermal disorders including neurofibromatosis, von Hippel-Landau's disease 
and congenital cataracts should be kept in mind. 
3) A thorough search for pheochromocytoma should be made in all patients 
and families in whom the diagnosis of neurofibromatosis or medullary carcinoma of 
the thyroid gland has been detected. 
We wish to thank Misses Betty Jo Handy and Sandra Schaft for their help in preparing 
the manuscript. We are also indebted to Miss G. Stuart R.N. and Miss E. Bracey who 
performed many of the blood pressure studies. 
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Table I I 
AGE AT DISCOVERY OF FAMILIAL PHEOCHROMOCYTOMA 
RELATED TO FAMILY GENERATION 
GENERATION 
* F A M 1 L Y I I I I I I 
A 18 39-44-50 
B 26 17 
F 26 16-6 
G 25 4- 8-6 
H 26 3 
J 27 22-17 
K 58 36-32 
L 62 31-30-15 
M 57 20-17 
N 32 33 
P 32 
Q 34 17-13 11 
s 54 37-21-21 6-11 
T 18 
• see Table I . 
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